GGrantIndex
Sort

40,608 grants matching prostate cancer

Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance

$304,359
Lorelei Mucci · Dana-Farber Cancer Inst · P50 · FY2013 · CA

Developing the Dietary Inflammatory Index for Clinical Application

$304,339
Nitin Shivappa · Connecting Health Innovations, Llc · R44 · FY2014 · DK

Novel Targets of Indoles in Prostate Cancer

$304,318
Fazlul H. Sarkar · Wayne State University · R01 · FY2010 · CA

Chemical Probes of Immunoproteasome Function in Cancer

$304,313
Kyung Bo Kim · University Of Kentucky · R01 · FY2010 · CA

Development and specificity of endogeneous tumor-infiltrating regulatory T cells

$304,278
Peter Aidan Savage · University Of Chicago · R01 · FY2013 · CA

Precision Interception of Aggressive Prostate Cancer in African American Men

$304,262
Franklin W Huang · Dana-Farber Cancer Inst · P20 · FY2019 · CA

CANCER AND INFLAMMATION: FUNCTION AND THERAPY

$304,238
Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods

$304,236
Kaushal Rege · Arizona State University-Tempe Campus · R01 · FY2011 · GM

MEDICAL THERAPY IN BENIGN PROSTATIC HYPERPLASIA

$304,209
Baylor College Of Medicine · U01 · FY2000 · DK

International Differences in Health, Longevity, and SES

$304,199
James Patrick Smith · Rand Corporation · R01 · FY2013 · AG

PET Proliferation Tracers

$304,178
Jeffrey L Schwartz · University Of Washington · R01 · FY2012 · CA

Cognitive impairment associated with androgen deprivation therapy for prostate cancer

$304,178
David A Morilak · University Of Texas Hlth Science Center · R01 · FY2021 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$304,169
Johns Hopkins University · U10 · FY2001 · CA

FoxP3 as the X-Linked Breast Cancer Suppressor Gene

$304,163
Yang Liu · University Of Michigan At Ann Arbor · R01 · FY2009 · CA

Apoptosis by FADD in normal and cancerous cells

$304,150
University Of Colorado Denver · R01 · FY2005 · CA

Nanovectors For Brain Tumor Diagnosis And Treatment

$304,131
Miqin Zhang · University Of Washington · R01 · FY2007 · CA

Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm

$304,127
Richard G Vile · Mayo Clinic Rochester · R01 · FY2012 · CA

Clinical Impact of B7-H Immune Cell Coregulators in Renal Cell Carcinoma

$304,127
Eugene D. Kwon · Mayo Clinic Rochester · R01 · FY2012 · CA

Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm

$304,127
Richard G Vile · Mayo Clinic Rochester · R01 · FY2011 · CA

Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB

$304,118
Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA

HYPOXIA AND PRX1 IN FINASTERIDE AND SELENIUM INTERVENTION OF PROSTATE CANCER

$304,113
Young-Mee Park · Roswell Park Cancer Institute Corp · P01 · FY2009 · CA

Role of Androgen Receptor Phosphorylation in Prostate Cancer

$304,099
Daniel G Gioeli · University Of Virginia · R01 · FY2011 · CA

Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis

$304,089
Hamid Ghandehari · University Of Utah · R01 · FY2023 · CA

Chemoprevention of Head & Neck Cancer Using Controlled Release Polymers

$304,087
Susan R Mallery · Ohio State University · R01 · FY2011 · CA

Protection of Salivary Gland in PSMA-targeted radioligand therapy

$304,086
Frank Lin · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA